0001209191-23-041027.txt : 20230705 0001209191-23-041027.hdr.sgml : 20230705 20230705161804 ACCESSION NUMBER: 0001209191-23-041027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230701 FILED AS OF DATE: 20230705 DATE AS OF CHANGE: 20230705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alder Matthias CENTRAL INDEX KEY: 0001370820 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40237 FILM NUMBER: 231069216 MAIL ADDRESS: STREET 1: C/O MICROMET, INC. STREET 2: 6707 DEMOCRACY BLVD., STE. 505 CITY: BETHESDA STATE: MD ZIP: 28017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gain Therapeutics, Inc. CENTRAL INDEX KEY: 0001819411 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851726310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: (301) 500-1556 MAIL ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-07-01 0 0001819411 Gain Therapeutics, Inc. GANX 0001370820 Alder Matthias C/O GAIN THERAPEUTICS, INC. 4800 MONTGOMERY LANE, SUITE 220 BETHESDA MD 20814 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-07-01 4 M 0 3300 A 3300 D Restricted Stock Units 2023-07-01 4 M 0 3300 0.00 D Common Stock 3300 9900 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date. /s/ Jason Minio, Attorney-in-Fact 2023-07-05